Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Assaf Marcus & Zelig Eshhar. (2014) Allogeneic chimeric antigen receptor-modified cells for adoptive cell therapy of cancer. Expert Opinion on Biological Therapy 14:7, pages 947-954.
Read now
Read now
Uluhan Sili, Ann M. Leen, Juan F. Vera, Adrian P. Gee, Helen Huls, Helen E. Heslop, Catherine M. Bollard & Cliona M. Rooney. (2012) Production of good manufacturing practice-grade cytotoxic T lymphocytes specific for Epstein–Barr virus, cytomegalovirus and adenovirus to prevent or treat viral infections post-allogeneic hematopoietic stem cell transplant. Cytotherapy 14:1, pages 7-11.
Read now
Read now
Articles from other publishers (28)
Nicolas Lambert, Majdouline El Moussaoui, Frédéric Baron, Pierre Maquet & Gilles Darcis. (2023) Virus-Specific T-Cell Therapy for Viral Infections of the Central Nervous System: A Review. Viruses 15:7, pages 1510.
Crossref
Crossref
Britta Eiz-Vesper, Sarina Ravens & Britta Maecker-Kolhoff. (2023) αβ and γδ T-cell responses to Epstein-Barr Virus: insights in immunocompetence, immune failure and therapeutic augmentation in transplant patients. Current Opinion in Immunology 82, pages 102305.
Crossref
Crossref
David H. Quach, Premal Lulla & Cliona M. Rooney. (2023) Banking on virus-specific T cells to fulfill the need for off-the-shelf cell therapies. Blood 141:8, pages 877-885.
Crossref
Crossref
Amadeus T Heinz, Friso G.J. Calkoen, Alexander Derbich, Lea Miltner, Christian Seitz, Michaela Doering, Christiane Braun, Daniel Atar, Michael Schumm, Florian Heubach, Anne-Marie Arendt, Ansgar Schulz, Friedhelm R Schuster, Roland Meisel, Brigitte Strahm, Juergen Finke, Beatrice Heineking, Susanne Stetter, Gerda Silling, Daniel Stachel, Bernd Gruhn, Klaus-Michael Debatin, Juergen Foell, Johannes H Schulte, Wilhelm Woessmann, Christine Mauz-Körholz, Johanna Tischer, Tobias Feuchtinger, Rupert Handgretinger & Peter Lang. (2023) Automated production of specific T cells for treatment of refractory viral infections after allogeneic stem cell transplantation. Haematologica 108:8, pages 2080-2090.
Crossref
Crossref
Karen Kai-Lin Fang, Jong Bok Lee & Li Zhang. (2022) Adoptive Cell Therapy for T-Cell Malignancies. Cancers 15:1, pages 94.
Crossref
Crossref
Friederike C. Schulze Lammers, Agnes Bonifacius, Sabine Tischer-Zimmermann, Lilia Goudeva, Jörg Martens, Bernd Lepenies, Maria von Karpowitz, Gunilla Einecke, Gernot Beutel, Thomas Skripuletz, Rainer Blasczyk, Rita Beier, Britta Maecker-Kolhoff & Britta Eiz-Vesper. (2022) Antiviral T-Cell Frequencies in a Healthy Population: Reference Values for Evaluating Antiviral Immune Cell Profiles in Immunocompromised Patients. Journal of Clinical Immunology 42:3, pages 546-558.
Crossref
Crossref
Annalisa Marcuzzi, Erika Rimondi, Elisabetta Melloni, Floriana Zennaro, Aurelio Sonzogni, Sara Leo & Natalia Maximova. (2022) Acute Neurological Involvement after Donor Lymphocyte Infusion for Post-Transplant Viral Infection: The Same Pattern of Novel Cancer Immunotherapy-Related CNS Toxicity?. International Journal of Molecular Sciences 23:7, pages 3553.
Crossref
Crossref
Mahshid Mehdizadeh, Samira Karami, Haniyeh Ghaffari Nazari, Ghazaleh Sankanian, Mohsen Hamidpour & Abbas Hajifathali. (2021) Immunotherapy with adoptive cytomegalovirus‐specific T cells transfer: Summarizing latest gene engineering techniques. Health Science Reports 4:3.
Crossref
Crossref
Sanjana Fatema Chowdhury & Saeed Anwar. (2020) Management of Hemoglobin Disorders During the COVID-19 Pandemic. Frontiers in Medicine 7.
Crossref
Crossref
Theresa Kaeuferle, Ramona Krauss, Franziska Blaeschke, Semjon Willier & Tobias Feuchtinger. (2019) Strategies of adoptive T -cell transfer to treat refractory viral infections post allogeneic stem cell transplantation. Journal of Hematology & Oncology 12:1.
Crossref
Crossref
Noga Or-Geva, Rotem Gidron-Budovsky, Rakefet Sidlik-Muskatel, Aloukick Kumar Singh & Yair Reisner. (2019) Next-generation CD8 memory veto T cells directed against memory antigens. Leukemia 33:11, pages 2737-2741.
Crossref
Crossref
Sung-Yeon Cho, Dong-Gun Lee & Hee-Je Kim. (2019) Cytomegalovirus Infections after Hematopoietic Stem Cell Transplantation: Current Status and Future Immunotherapy. International Journal of Molecular Sciences 20:11, pages 2666.
Crossref
Crossref
A. Quaiser & U. Köhl. (2018) Was ist gesichert bei den Zelltherapien?What is established in cell therapies?. Der Internist 59:12, pages 1230-1238.
Crossref
Crossref
Lauren P. McLaughlin, Catherine M. Bollard & Michael Keller. (2017) Adoptive T Cell Immunotherapy for Patients with Primary Immunodeficiency Disorders. Current Allergy and Asthma Reports 17:1.
Crossref
Crossref
Marsela Qesari, Anne Richter, Justyna Ogonek, Eva Mischak-Weissinger, Xiao-nong Wang & Anne M. Dickinson. (2016) Cytomegalovirus-Specific T Cells Isolated by IFN-γ Secretion Assay Do Not Induce Significant Graft-Versus-Host Reactions In Vitro. Transplantation 100:11, pages 2352-2361.
Crossref
Crossref
Swati Naik, Sarah K. Nicholas, Caridad A. Martinez, Ann M. Leen, Patrick J. Hanley, Steven M. Gottschalk, Cliona M. Rooney, I. Celine Hanson, Robert A. Krance, Elizabeth J. Shpall, Conrad R. Cruz, Persis Amrolia, Giovanna Lucchini, Nancy Bunin, Jennifer Heimall, Orly R. Klein, Andrew R. Gennery, Mary A. Slatter, Mark A. Vickers, Jordan S. Orange, Helen E. Heslop, Catherine M. Bollard & Michael D. Keller. (2016) Adoptive immunotherapy for primary immunodeficiency disorders with virus-specific T lymphocytes. Journal of Allergy and Clinical Immunology 137:5, pages 1498-1505.e1.
Crossref
Crossref
Yu Xiong, Dani?le Bensoussan & V?ronique Decot. (2015) Adoptive Immunotherapies After Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Hematologic Malignancies. Transfusion Medicine Reviews 29:4, pages 259-267.
Crossref
Crossref
Sabine Tischer, Daria Dieks, Cinja Sukdolak, Carola Bunse, Constanca Figueiredo, Stephan Immenschuh, Sylvia Borchers, Renata Stripecke, Britta Maecker-Kolhoff, Rainer Blasczyk & Britta Eiz-Vesper. (2014) Evaluation of suitable target antigens and immunoassays for high-accuracy immune monitoring of cytomegalovirus and Epstein–Barr virus-specific T cells as targets of interest in immunotherapeutic approaches. Journal of Immunological Methods 408, pages 101-113.
Crossref
Crossref
Marco Zecca, Rita Maccario, Sabrina Basso & Patrizia Comoli. (2014) Possible alternatives to antimicrobial therapies. Early Human Development 90, pages S16-S18.
Crossref
Crossref
Pradip Bajgain, Roopa Mucharla, John Wilson, Dan Welch, Usanarat Anurathapan, Bitao Liang, Xiaohua Lu, Kyle Ripple, John M Centanni, Christine Hall, David Hsu, Larry A Couture, Shubhranshu Gupta, Adrian P Gee, Helen E Heslop, Ann M Leen, Cliona M Rooney & Juan F Vera. (2014) Optimizing the production of suspension cells using the G-Rex “M” series. Molecular Therapy - Methods & Clinical Development 1, pages 14015.
Crossref
Crossref
Kewal K. JainKewal K. Jain. 2014. Applications of Biotechnology in Oncology. Applications of Biotechnology in Oncology
473
507
.
Winnie WY Ip & Waseem Qasim. (2013) Management of Adenovirus in Children after Allogeneic Hematopoietic Stem Cell Transplantation. Advances in Hematology 2013, pages 1-12.
Crossref
Crossref
Sylvain Olivero, Flavia Spirito, Caroline Mouline, Laurence Fantin, Janet L. Maryanski, Wafa Khaali, Juliette Thariat, Laetitia Albano & Alain Doglio. (2012) Traitement par lymphothérapie adoptive des infections virales chez les patients transplantés : de réelles raisons d’espérer. Revue Francophone des Laboratoires 2012:447, pages 83-92.
Crossref
Crossref
John A Barrett. (2012) T-Cell Therapy for Viral Infections Following Transplantation: Why Stop at Three Viruses?. Molecular Therapy 20:8, pages 1487-1488.
Crossref
Crossref
Lamia Aïssi-Rothé, Véronique Decot, Ying Ying Wang, Jean-François Stoltz & Danièle Bensoussan. (2012) Apport des méthodes d’isolement immunomagnétique de lymphocytes T cytotoxiques dans la restauration rapide d’une immunité antivirale après allogreffe de cellules souches hématopoïétiques. Revue Francophone des Laboratoires 2012:439, pages 55-60.
Crossref
Crossref
Cliona Rooney & Ann Leen. (2012) Moving Successful Virus-specific T-cell Therapy for Hematopoietic Stem Cell Recipients to Late Phase Clinical Trials. Molecular Therapy - Nucleic Acids 1, pages e55.
Crossref
Crossref
C. Aspord, D. Laurin, M.-J. Richard, H. Vie, L. Chaperot & J. Plumas. (2011) Induction of Antiviral Cytotoxic T Cells by Plasmacytoid Dendritic Cells for Adoptive Immunotherapy of Posttransplant Diseases. American Journal of Transplantation 11:12, pages 2613-2626.
Crossref
Crossref
Nina Khanna, Claudia Stuehler, Barbara Conrad, Sarah Lurati, Sven Krappmann, Hermann Einsele, Carsten Berges & Max S. Topp. (2011) Generation of a multipathogen-specific T-cell product for adoptive immunotherapy based on activation-dependent expression of CD154. Blood 118:4, pages 1121-1131.
Crossref
Crossref